You are here:Home-Chemical Inhibitors & Agonists-TGF-beta/Smad-TGF beta Receptor (TGFBR)-BMS-986260
BMS-986260

Chemical Structure : BMS-986260

CAS No.: 2001559-19-7

BMS-986260 (BMS986260)

Catalog No.: PC-72168Not For Human Use, Lab Use Only.

BMS-986260 (BMS 986260) is a potent, selective, and orally bioavailable TGFβR1 inhibitor with IC50 of 1.6 nM, negligible inhibition against TGFβR2 (IC50>15 uM).

Packing Price Stock Quantity
25 mg Get quote
100 mg Get quote
250 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

BMS-986260 (BMS 986260) is a potent, selective, and orally bioavailable TGFβR1 inhibitor with IC50 of 1.6 nM, negligible inhibition against TGFβR2 (IC50>15 uM).
BMS-986260 is a highly potent TGFβR1 inhibitor in both human (Kiapp=0.8 nM) and mouse (Kiapp=1.4 nM) biochemical assays, and displays exquisite selectivity for TGFβR1 over its isozyme TGFβR2, as well as in a panel of >200 kinases.
BMS-986260 inhibited phosphorylation and subsequent nuclear translocation of SMAD in mink lung epithelial (MvLu1) cells and normal human lung fibroblasts (NHLF) cells with IC50 of 0.35 and 0.19 uM, respectively, also inhibited TGFβ induced SMAD phosphorylation in NIH3T3 cell line, primary human T cells, and mouse and human whole blood, inhibited TGF-β mediated induction of Treg by downregulation of FOXP3 expression and a repression of CD25 with IC50 of 230 nM.
Combination of BMS-986260 with anti-PD-1-antibody demonstrated robust antitumor efficacy, correlated with pSMAD2/3 inhibition and increase in intratumoral CD8+ T-cells, BMS-986260 also inhibited metastasis to the lungs in a 4T1 syngeneic orthotopic mammary tumor model.

Physicochemical Properties

M.Wt 382.783
Formula C18H12ClFN6O
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Month
Shipping
Solubility

Chemical Name/SMILES

References

1. Velaparthi U, et al. ACS Med Chem Lett. 2020 Jan 28;11(2):172-178.

2. Parrish KE, et al. Biopharm Drug Dispos. 2021 Apr;42(4):137-149.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: